The round was led by Menlo Ventures, with backing from Thrive Capital, Index Ventures, J.P
What Some Of The Evidence Shows So Far Research on microdosing is limited, with most insights coming from anecdotal accounts rather than controlled clinical trials
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
View all frequently asked questions RELATED PRODUCTS Chonluten Chonluten is a short tripeptide bioregulator composed of the amino acid sequence Glu-Asp-Gly (EDG), originally isolated from bronchial epithelial cells.
Between 20%-50% of weight lost on GLP-1 drugs is muscle loss
TB-500, a synthetic fragment of thymosin beta-4 originating from thymus peptide research of the 1960s, has been examined in studies of angiogenesis and cellular migration